Shield Therapeutics plc (STX) — Tangible Net Worth Ratio
Shield Therapeutics plc (STX) has a Tangible Net Worth Ratio of -3116.5% as of June 2024. This metric is calculated by deducting intangible assets (GBX13.77 Million) from net assets (GBX427.97K) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See STX working capital efficiency to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Shield Therapeutics plc Tangible Net Worth Ratio (2016–2023)
This chart shows how Shield Therapeutics plc's Tangible Net Worth Ratio has changed across 8 annual periods from 2016 to 2023. As of June 2024, the ratio stands at -3116.5%, reflecting net assets of GBX427.97K with intangible assets of GBX13.77 Million GBX. See Shield Therapeutics plc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Shield Therapeutics plc (2016–2023)
The table below presents the year-by-year Tangible Net Worth Ratio for Shield Therapeutics plc from 2016 to 2023, covering 8 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see Shield Therapeutics plc (STX) market capitalisation.
| Year | Tangible NW Ratio | Net Assets (GBX) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 24.4% | GBX22.31 Million | GBX16.86 Million | GBX48.80 Million | ▲ +141.5 pp |
| 2022 | -117.1% | GBX5.43 Million | GBX11.78 Million | GBX22.07 Million | ▼ -151.7 pp |
| 2021 | 34.6% | GBX41.03 Million | GBX26.85 Million | GBX44.41 Million | ▲ +24.6 pp |
| 2020 | 9.9% | GBX30.28 Million | GBX27.27 Million | GBX32.53 Million | ▲ +3.0 pp |
| 2019 | 7.0% | GBX32.15 Million | GBX29.90 Million | GBX36.32 Million | ▼ -16.4 pp |
| 2018 | 23.4% | GBX40.43 Million | GBX30.96 Million | GBX43.38 Million | ▼ -3.9 pp |
| 2017 | 27.3% | GBX41.21 Million | GBX29.96 Million | GBX44.97 Million | ▼ -12.8 pp |
| 2016 | 40.1% | GBX48.40 Million | GBX28.98 Million | GBX52.38 Million | — |